Germany Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication and Telepathology), End User (Educational Institutes, Hospitals and Diagnostic Centers and Pharmaceutical and Biotechnology Companies) - Opportunity Analysis and Industry Forecast, 2014-2022

CHAPTER 1 INTRODUCTION

1.1 Report description

1.1 Key benefits

1.2 Key market segment

1.3 Research methodology

1.3.1 Secondary research

1.3.2 Primary research

1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.2 Key findings

3.2.1 Top winning strategies

3.3 Conventional pathology vs. digital pathology

3.4 Key player positioning, 2015

3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Use of digital pathology in cancer diagnosis

3.5.1.2 Cost efficiency

3.5.1.3 Ease in transportation

3.5.1.4 High efficiency

3.5.1.5 Efficient analysis

3.5.1.6 System efficiency

3.5.1.7 Efficiency in workflow

3.5.1.8 Diagnosis in remote regions

3.5.2 Restraints

3.5.2.1 Lack of reimbursement

3.5.2.2 Lack of infrastructure in developing economies

3.5.2.3 Resistance towards adoption of digital pathology

3.5.3 Opportunities

3.5.3.1 Rising awareness pertaining to digital pathology

3.5.3.2 Increasing potential of digital pathology

CHAPTER 4 GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast

4.1.2 Whole slide imaging (WSI)

4.1.2.1 Market size and forecast

4.1.3 Image analysis informatics

4.1.3.1 Market size and forecast

4.1.4 Information management system storage & communication

4.1.4.1 Market size and forecast

4.1.5 Telepathology

4.1.5.1 Market size and forecast

CHAPTER 5 GERMANY DIGITAL PATHOLOGY MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast

5.1.2 Educational institutes

5.1.2.1 Market size and forecast

5.1.3 Hospitals and diagnostic centers

5.1.3.1 Market size and forecast

5.1.4 Pharmaceutical and biotechnology companies

5.1.4.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Danaher Corporation (Leica Microsystem)

6.1.1 Company Overview

6.1.2 Company Snapshot

6.1.3 Operating Business Segments

6.1.4 Business Performance

6.1.5 Key Strategic Moves & Developments

6.2 Definiens AG

6.2.1 Company Overview

6.2.2 Company Snapshot

6.2.3 Business Performance

6.2.4 Key Strategic Moves & Developments

6.3 Carl Zeiss AG

6.3.1 Company Overview

6.3.2 Company Snapshot

6.3.3 Operating Business Segments

6.3.4 Business Performance

6.3.5 Key Strategic Moves and Developments

6.4 VMscope GmbH

6.4.1 Company Overview

6.4.2 Company Snapshot

6.4.3 Operating Business Segments

6.4.4 Business Performance

6.4.5 Key Strategic Moves and Developments

6.5 microDimensions GmbH

6.5.1 Company Overview

6.5.2 Company Snapshot

6.5.3 Operating Business Segments

6.5.4 Business Performance

6.5.5 Key Strategic Moves and Developments

6.6 Visiopharm

6.6.1 Company Overview

6.6.2 Company Snapshot

6.6.3 Operating Business Segments

6.6.4 Business Performance

6.6.5 Key Strategic Moves & Developments

6.7 Koninklijke Philips N.V.

6.7.1 Company Overview

6.7.2 Company Snapshot

6.7.3 Operating Business Segments

6.7.4 Business Performance

6.7.5 Key Strategic Moves & Developments

6.8 PerkinElmer, Inc.

6.8.1 Company Overview

6.8.2 Company Snapshot

6.8.3 Operating Business Segments

6.8.4 Business Performance

6.8.5 Key Strategic Moves & Developments

6.9 Nikon Corporation

6.9.1 Company Overview

6.9.2 Company Snapshot

6.9.3 Operating Business Segments

6.9.4 Business Performance

6.9.5 Key Strategic Moves & Developments

6.10 Digipath, Inc.

6.10.1 Company Overview

6.10.2 Company Snapshot

6.10.3 Operating Business Segments

6.10.4 Key Strategic Moves & Developments

Other players in the value chain include:

• Indica Labs
• Hamamatsu Photonics Europe GmbH
• Pixcelldata Ltd.
• Glencoe Software Inc.

*Profiles of these players are not included. The same will be included on request.

List of Figures

FIG. 1 DATA TRIANGULATION METHODOLOGY

FIG. 2 PRIMARY AND SECONDARY RESEARCH

FIG. 3 INDUSTRY PARTICIPANTS FROM SUPPLY SIDE

FIG. 4 INDUSTRY PARTICIPANTS FROM DEMAND SIDE

FIG. 5 GERMANY DIGITAL PATHOLOGY MARKET, 2015 VS 2022, ($MILLION)

FIG. 6 DIGITAL PATHOLOGY: MARKET DEFINITION

FIG. 7 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION

FIG. 8 TYPES OF STRATEGIES DISTRIBUTION

FIG. 9 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES

FIG. 10 KEY PLAYER POSITIONING, 2015

FIG. 11 TOP IMPACTING FACTORS: GERMANY DIGITAL PATHOLOGY MARKET (20142022)

FIG. 12 DIGITAL PATHOLOGY: WORKFLOW

FIG. 13 GERMANY: WHOLE SLIDE IMAGING MARKET, 20142022 ($MILLION)

FIG. 14 GERMANY: IMAGE ANALYSIS INFORMATICS MARKET, 20142022 ($MILLION)

FIG. 15 INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION: STORAGE WORKFLOW

FIG. 16 GERMANY: INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION MARKET, 20142022 ($MILLION)

FIG. 17 GERMANY: TELEPATHOLOGY MARKET, 20142022 ($MILLION)

FIG. 18 GERMANY: EDUCATIONAL INSTITUTES END USER MARKET, 20142022 ($MILLION)

FIG. 19 GERMANY: HOSPITALS AND DIAGNOSTIC END USER MARKET, 20142022 ($MILLION)

FIG. 20 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY END USER MARKET, 20142022 ($MILLION)

FIG. 21 DANAHER: NET SALES, 20132015 ($MILLION)

FIG. 22 DANAHER: REVENUE, BY BUSINESS SEGMENT, 2015 (%)

FIG. 23 DANAHER: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 24 DANAHER: STRATEGY SHARE, 20122015 (%)

FIG. 25 DEFINIENS: STRATEGY SHARE, 20142016 (%)

FIG. 26 CARL ZEISS: REVENUE, 20132015 ($MILLION)

FIG. 27 CARL ZEISS: REVENUE, BY SEGMENT, 2015 (%)

FIG. 28 CARL ZEISS: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 29 CARL ZEISS: STRATEGY SHARE, 2016 (%)

FIG. 30 VMSCOPE: STRATEGY SHARE, 20132015 (%)

FIG. 31 VISIOPHARM: STRATEGY SHARE, 20142016 (%)

FIG. 32 PHILIPS HEALTHCARE: NET SALES, 20132015 ($MILLION)

FIG. 33 PHILIPS HEALTHCARE: REVENUE, BY BUSINESS SEGMENT, 2015 (%)

FIG. 34 KONINKLIJKE PHILIPS N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 35 PHILIPS HEALTHCARE: STRATEGY SHARE, 20142016 (%)

FIG. 36 PERKINELMER, INC.: NET SALES, 20132015 ($MILLION)

FIG. 37 PERKINELMER INC.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)

FIG. 38 PERKINELMER INC.: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 39 PERKINELMER INC.: STRATEGY SHARE, 20142016 (%)

FIG. 40 NIKON: NET SALES, 20132015 ($MILLION)

FIG. 41 NIKON: REVENUE, BY BUSINESS SEGMENT, 2015 (%)

FIG. 42 NIKON: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 43 DIGIPATH: STRATEGY SHARE, 20132014 (%)

List of Table

TABLE 1 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 20142022 ($MILLION)

TABLE 2 GERMANY: WHOLE SLIDE IMAGING MARKET, 20142022 ($MILLION)

TABLE 3 GERMANY: IMAGE ANALYSIS INFORMATICS MARKET, 20142022 ($MILLION)

TABLE 4 GERMANY: INFORMATION MANAGEMENT SYSTEM STORAGE & COMMUNICATION MARKET, 20142022 ($MILLION)

TABLE 5 GERMANY: TELEPATHOLOGY MARKET, 20142022 ($MILLION)

TABLE 6 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 20142022 ($MILLION)

TABLE 7 GERMANY: EDUCATIONAL INSTITUTES END USER MARKET, 20142022 ($MILLION)

TABLE 8 GERMANY: HOSPITALS & DIAGNOSTIC CENTERS END USER MARKET, 20142022 ($MILLION)

TABLE 9 GERMANY: PHARMACEUTICAL & BIOTECHNOLOGY END USER MARKET, 20142022 ($MILLION)

TABLE 10 DANAHER: COMPANY SNAPSHOT

TABLE 11 DANAHER: OPERATING SEGMENTS

TABLE 12 DEFINIENS: COMPANY SNAPSHOT

TABLE 13 CARL ZEISS: COMPANY SNAPSHOT

TABLE 14 CARL ZEISS: OPERATING SEMENTS

TABLE 15 VMSCOPE: COMPANY SNAPSHOT

TABLE 16 VMSCOPE: OPERATING SEGMENT

TABLE 17 MICRODIMENSIONS GMBH: COMPANY SNAPSHOT

TABLE 18 MICRODIMENSIONS: OPERATING SEGMENT

TABLE 19 VISIOPHARM: COMPANY SNAPSHOT

TABLE 20 VISIOPHARM: OPERATING SEGMENTS

TABLE 21 KONINKLIJKE PHILIPS N. V.: COMPANY SNAPSHOT

TABLE 22 PHILIPS HEALTHCARE: OPERATING SEGMENTS

TABLE 23 PERKINELMER INC.: COMPANY SNAPSHOT

TABLE 24 PERKINELMER INC.: OPERATING SEGMENTS

TABLE 25 NIKON: COMPANY SNAPSHOT

TABLE 26 NIKON: OPERATING SEGMENTS

TABLE 27 DIGIPATH, INC: COMPANY SNAPSHOT

TABLE 28 DIGIPATH: OPERATIN